Semaglutide Sublingual offers a provider-directed alternative to injectable GLP-1 therapy for patients who prefer a needle-free treatment option. Administered under the tongue, it helps support appetite regulation and long-term weight management as part of a personalized care plan.
Semaglutide Sublingual may be appropriate for patients looking for a provider-directed, needle-free GLP-1 option. Your provider will determine whether this formulation aligns with your treatment goals.